Cohorts, INJ-01, Spring 2027.

Injury Repair and Regeneration. Twelve weeks of injury repair peptide pharmacology and protocol design. BPC-157, TB-500, growth-factor peptides, and the case review clinic focused on orthopedic and soft-tissue injury.

Announced, enrollment opens in Phase 2. Runs 2027-04-12 through 2027-07-05, 12 weeks. Led by Elena Brown, PharmD .

Be notified when enrollment opens. Or request access to be notified.

At a Glance

Specs
  • Code INJ-01 Spring 2027
  • Length 12 weeks 2027-04-12 to 2027-07-05
  • Seats 20 maximum, 20 remaining First-come
  • Price $2,400, illustrative Per member
  • Lead Elena Brown, PharmD Faculty lead

Curriculum

Twelve weeks, one topic per week. Case review clinic sessions are woven in on weeks 5, 8, and 12. The schedule is firm; topics may be refined based on the working cases in a given cohort.

Weekly
  • Wk 1 Repair biology overview 90 min live
  • Wk 2 BPC-157 mechanisms 90 min live
  • Wk 3 TB-500 and actin regulation 90 min live
  • Wk 4 GH-axis adjuncts in repair 90 min live
  • Wk 5 Case review clinic, orthopedic focus 90 min live

Who This Is For

Practicing clinicians and scientists who want weekly faculty contact on a single therapeutic area, and who are willing to present anonymized cases for discussion. Not a primer. Comfort with the self-paced foundational material is assumed; a member can work through the public curriculum before applying.